A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine

Clinical trial NCT04975893 · COMPLETED

Trial details

NCT number: NCT04975893
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infection

Start date: 2021-06-18
Primary completion: 2026-01-19
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.